NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | 0.0% | 285 | +13.5% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 251 | +151.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 100 | +49.3% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 67 | +17.5% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 57 | -52.5% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 120 | +531.6% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 19 | -5.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 20 | +5.3% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 19 | -95.4% | 0.00% | -100.0% |
| Q1 2018 | $44,000 | +83.3% | 412 | +2.5% | 0.01% | +66.7% |
| Q4 2017 | $24,000 | – | 402 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |